[HTML][HTML] Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
PSMA PET imaging was originally used to assess biochemical recurrence of prostate cancer
(PCa), but its clinical use was promptly extended to detection, staging and therapy response …
(PCa), but its clinical use was promptly extended to detection, staging and therapy response …
Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …
Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer
Molecular profiling of circulating extracellular vesicles (EVs) provides a promising
noninvasive means to diagnose, monitor, and predict the course of metastatic breast cancer …
noninvasive means to diagnose, monitor, and predict the course of metastatic breast cancer …
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
A Afshar-Oromieh, T Holland-Letz, FL Giesel… - European journal of …, 2017 - Springer
Purpose Since the clinical introduction of 68 Ga-PSMA-11 PET/CT, this imaging method has
rapidly spread and is now regarded as a significant step forward in the diagnosis of …
rapidly spread and is now regarded as a significant step forward in the diagnosis of …
Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a call to arms
RAS Fragomeni, T Amir, S Sheikhbahaei… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein that is
highly overexpressed on prostate cancer epithelial cells and for which there is a growing …
highly overexpressed on prostate cancer epithelial cells and for which there is a growing …
Radiolabeled peptides and antibodies in medicine
P Kręcisz, K Czarnecka, L Królicki… - Bioconjugate …, 2020 - ACS Publications
Radiolabeled peptides are a relatively new, very specific radiotracer group, which is still
expanding. This group is very diverse in terms of peptide size. It contains very small …
expanding. This group is very diverse in terms of peptide size. It contains very small …
Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives
P Backhaus, B Noto, N Avramovic, LS Grubert… - European journal of …, 2018 - Springer
Background Prostate-specific membrane antigen (PSMA) is the up-and-coming target for
molecular imaging of prostate cancer. Despite its name, non-prostate-related PSMA …
molecular imaging of prostate cancer. Despite its name, non-prostate-related PSMA …
The role of PET/CT in breast cancer
B Hadebe, L Harry, T Ebrahim, V Pillay, M Vorster - Diagnostics, 2023 - mdpi.com
Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer
worldwide, with an estimated 2.3 million new cases (11.7%), followed by lung cancer …
worldwide, with an estimated 2.3 million new cases (11.7%), followed by lung cancer …
68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli?
T Lengana, IO Lawal, TG Boshomane… - Clinical genitourinary …, 2018 - Elsevier
Purpose 68 Ga ligands targeting prostate-specific membrane antigen (PSMA) are rapidly
emerging as a significant step forward in the management of prostate cancer. PSMA is a …
emerging as a significant step forward in the management of prostate cancer. PSMA is a …
[HTML][HTML] Radiotheranostics-precision medicine in nuclear medicine and molecular imaging
Abstract'See what you treat and treat what you see, at a molecular level', could be the motto
of theranostics. The concept implies diagnosis (imaging) and treatment of cells (usually …
of theranostics. The concept implies diagnosis (imaging) and treatment of cells (usually …